Patents-Review.com
ClassID:

110977 ⎘

C12N2760/18521 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Paramyxoviridae; Pneumovirus, e.g. human respiratory syncytial virus Viruses as such, e.g. new isolates, mutants or their genomic sequences

Recent Application in this class:
#1
20260152727
2026-06-04

Modified Viral Genome Compositions and Methods of Production and Use Thereof

 #2
20260115274
2026-04-30

RSV Vaccines with Truncated G-Protein Mucin Domains

 #3
20250115881
2025-04-10

MODIFIED VERO CELLS AND METHODS OF USING THE SAME FOR VIRUS PRODUCTION

 #4
20240398932
2024-12-05

RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE

 #5
20230293660
2023-09-21

Chimeric RSV, immunogenic compositions, and methods of use

 #6
20230279362
2023-09-07

LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS

 #7
20220324917
2022-10-13

Recombinant RSV live vaccine strain and the preparing method thereof

 #8
20220315953
2022-10-06

MDBK IRF3/IRF7 KNOCK OUT MUTANT CELL AND ITS USE FOR VACCINE PRODUCTION

 #9
20210355169
2021-11-18

RECOMBINANT RSV LIVE VACCINE STRAIN AND PRODUCTION METHOD THEREFOR

 #10
20210177960
2021-06-17

Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts

 #11
20200283740
2020-09-10

Recombinant respiratory syncytial virus strains with mutations in the M2-2 ORF providing a range of attenuation phenotypes

 #12
20200069794
2020-03-05

Respiratory virus nucleic acid vaccines

 #13
20190282690
2019-09-19

Genetically stable live attenuated respiratory syncytial virus vaccine and its production

 #14
20190184000
2019-06-20

Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts

 #15
20190169577
2019-06-06

Respiratory syncytial virus having altered NS1 protein function and related materials and methods

 #16
20190055291
2019-02-21

Fusion respiratory syncytial virus inhibitors and use thereof

 #17
20190040365
2019-02-07

Recombinant respiratory syncytial virus stains with mutations in the M2-2 ORF providing a range of attenuation phenotypes

 #18
20190031741
2019-01-31

Human Antibodies to Respiratory Syncytial Virus F Protein and Methods of Use Thereof

 #19
20180333477
2018-11-22

Chimeric RSV, immunogenic compositions, and methods of use

 #20
20180207211
2018-07-26

Respiratory syncytial virus with a genomic deficiency complemented in trans

 #21
20170189520
2017-07-06

Genetically stable live attenuated respiratory syncytial virus vaccine and its production

 #22
20170130279
2017-05-11

Recombinant RSV reporter virus

 #23
20170029488
2017-02-02

Human antibodies to respiratory syncytial virus F protein and methods of use thereof

 #24
20160250319
2016-09-01

Thermostable respiratory synctial virus (RSV) vaccine compositions

 #25
20160228536
2016-08-11

RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) AND VACCINES

 #26
20150329833
2015-11-19

Respiratory syncytial virus with a genomic deficiency complemented in trans

 #27
20150299669
2015-10-22

Pneumovirus compositions and methods for using the same

 #28
20150118732
2015-04-30

Genetically stable live attenuated respiratory syncytial virus vaccine and its production

 #29
20140271653
2014-09-18

Human antibodies to respiratory syncytial virus F protein and methods of use thereof

 #30
20130011443
2013-01-10

Human respiratory syncytial virus vaccine

 #31
20120288522
2012-11-15

Pneumovirus compositions and methods for using the same

 #32
20100291035
2010-11-18

Respiratory syncytial virus with a genomic deficiency complemented in trans

 #33
20050158338
2005-07-21

Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions

 #34
20050089525
2005-04-28

Subunit respiratory syncytial virus vaccine preparation